Pfizer recalls millions of migraine prescription drug packs; Here’s what you need know

México Noticias Noticias

Pfizer recalls millions of migraine prescription drug packs; Here’s what you need know
México Últimas Noticias,México Titulares
  • 📰 aldotcom
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 68%

Pfizer is recalling more than four million packages of migraine medication.

Pfizer on March 16, 2023, recalled 4.2 million packages of the prescription drug Nurtec ODT, used to treat migraines. The medication was recalled because the packaging is not child-resistant and could be poisonous to children, according to the U.S. Consumer Product Safety Commission.

The company is recalling around 4.2 million units of Nurtec ODT 75mg orally disintegrating tablets, which are sold in packs of eight doses on a blister card, on Thursday, the U.S. Consumer Product Safety Commission said. “The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children,” it warned.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

aldotcom /  🏆 82. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Nurtec ODT recall: Pfizer to develop new packaging after product didn't meet child-resistant requirementsNurtec ODT recall: Pfizer to develop new packaging after product didn't meet child-resistant requirementsPfizer is recalling 4.2 million packages of Nurtec ODT 75 mg orally disintegrating tablets for failing to meet child-resistant requirements, according to safety regulators.
Leer más »

U.S. FDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidU.S. FDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidAdvisers to the U.S. health regulator on Thursday voted in favor of recommending a full approval for Pfizer's COVID-19 pill Paxlovid in adults at high risk of progression to severe disease.
Leer más »

FDA advisers back Pfizer's COVID treatment for full approvalFDA advisers back Pfizer's COVID treatment for full approvalAdvisers to the U.S. Food and Drug Administration on Thursday overwhelmingly backed full approval of Pfizer's oral antiviral COVID-19 treatment Paxlovid for adults at high risk of progression to severe disease.
Leer más »

FDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidFDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidU.S. health regulators voted in favor of a full approval for Pfizer's COVID pill Paxlovid. This pill will will help adults who are at high risk of progression to severe virus.
Leer más »

Pfizer ‘recalls’ 4.2 million boxes of Nurtec migraine medicine due to lack of childproofingPfizer ‘recalls’ 4.2 million boxes of Nurtec migraine medicine due to lack of childproofingPharmaceutical company Pfizer is “recalling” 4.2 million units of its migraine medication Nurtec because the single eight-count blister pack in each box is not adequately child-proofed.
Leer más »



Render Time: 2025-03-01 06:24:46